Account Executive at BillionToOne

United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, DiagnosticsIndustries

Requirements

Experience in diagnostic/genetic testing product sales
Experience in prenatal sales is preferred
Ability to deliver clinical information to both external clients throughout your territory and internal teams
Significant influence over how the test is communicated to physicians and patients, and how it should evolve to better serve market needs

Responsibilities

Increasing utilization of UNITY

Questions & Answers

Common questions about this position

What is the salary for the Account Executive position?

This information is not specified in the job description.

Is this Account Executive role remote or office-based?

The position is designated as Field location type, indicating it involves work in the field rather than remote or office-based.

What skills and experience are required for this Account Executive role?

Candidates need experience in diagnostic/genetic testing product sales, with prenatal sales experience preferred, plus the ability to deliver clinical information to clients and teams, and influence test communication to physicians and patients.

What is the company culture like at BillionToOne?

BillionToOne maintains a unique, diverse, passionate, and innovative culture despite significant growth, and has been recognized by Forbes as one of America's Best Startup Employers for 2024.

What makes a strong candidate for the Account Executive position?

A strong candidate will have experience in diagnostic or genetic testing product sales, preferably in prenatal sales, and demonstrate the ability to effectively communicate clinical information and influence product evolution based on market needs.

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$380.2MTotal Funding

SERIES_DCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.

Rapid technological advancements may render their current technology obsolete.

Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.

Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.

They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.

Their new Austin facility will create 1,000 jobs, boosting production and local economy.

Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI

Try Jobo Free